REPORTS

Let’s Pullulate and Expand Your Business

Global RNAi for Therapeutic Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Nov 05, 2019  |  162 PAGES  |  REPORT CODE: CMM229331
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The RNAi for Therapeutic is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period. The research provides insights for the global RNAi for Therapeutic market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the RNAi for Therapeutic industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global RNAi for Therapeutic Market Segmentations:

By Players:

  • Alnylam Pharmaceuticals

  • Ensysce Biosciences

  • Silenseed

  • Roche Innovation Center Copenhagen (formerly Santaris Pharma)

  • RXi Pharmaceuticals

  • Benitec Biopharma

  • Silence Therapeutics

  • Celsion Corporation

  • CombiMatrix

  • Biogazelle

  • Sylentis

  • Bayer Heathcare

  • Quark Pharmaceuticals

  • Arrowhead Research

  • Calando Pharmaceuticals

  • Celgene

  • Astellas Pharma

  • Tekmira Pharmaceuticals.

  • AstraZeneca

  • Ascletis Pharmaceuticals

  • GeneCopoeia

  • Gradalis Incorporated

  • Creative Animodel

  • BioSpring

By Types:

  • siRNA

  • miRNA

  • shRNA

By End-User:

  • Cancer

  • Cardiovascular

  • HBV

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of RNAi for Therapeutic Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global RNAi for Therapeutic Market Share by Types

    • 1.3.2 Global RNAi for Therapeutic Market Size and Growth Rate of siRNA from 2014 to 2026

    • 1.3.3 Global RNAi for Therapeutic Market Size and Growth Rate of miRNA from 2014 to 2026

    • 1.3.4 Global RNAi for Therapeutic Market Size and Growth Rate of shRNA from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global RNAi for Therapeutic Market Share by End-Users

    • 1.4.2 Global RNAi for Therapeutic Market Size and Growth Rate of Cancer from 2014 to 2026

    • 1.4.3 Global RNAi for Therapeutic Market Size and Growth Rate of Cardiovascular from 2014 to 2026

    • 1.4.4 Global RNAi for Therapeutic Market Size and Growth Rate of HBV from 2014 to 2026

    • 1.4.5 Global RNAi for Therapeutic Market Size and Growth Rate of Others from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina RNAi for Therapeutic Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of RNAi for Therapeutic Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of RNAi for Therapeutic by Major Types

    • 3.4.1 Market Size and Growth Rate of siRNA

    • 3.4.2 Market Size and Growth Rate of miRNA

    • 3.4.3 Market Size and Growth Rate of shRNA

4 Segmentation of RNAi for Therapeutic Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of RNAi for Therapeutic by Major End-Users

    • 4.4.1 Market Size and Growth Rate of RNAi for Therapeutic for Cancer

    • 4.4.2 Market Size and Growth Rate of RNAi for Therapeutic for Cardiovascular

    • 4.4.3 Market Size and Growth Rate of RNAi for Therapeutic for HBV

    • 4.4.4 Market Size and Growth Rate of RNAi for Therapeutic for Others

5 Market Analysis by Major Regions

  • 5.1 Global RNAi for Therapeutic Production Analysis by Major Regions

  • 5.2 Global RNAi for Therapeutic Consumption Analysis by Major Regions

  • 5.3 Global RNAi for Therapeutic Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America RNAi for Therapeutic Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe RNAi for Therapeutic Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific RNAi for Therapeutic Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa RNAi for Therapeutic Production, Import, Consumption and Export Analysis

6 Product Commodity of RNAi for Therapeutic Market in Major Countries

  • 6.1 Top 5 Export Countries in RNAi for Therapeutic market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in RNAi for Therapeutic market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in RNAi for Therapeutic market from 2014 to 2019

  • 6.2 Top 5 Import Countries in RNAi for Therapeutic market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in RNAi for Therapeutic market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in RNAi for Therapeutic market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America RNAi for Therapeutic Landscape Analysis

  • 7.1 North America RNAi for Therapeutic Landscape Analysis by Major Types

  • 7.2 North America RNAi for Therapeutic Landscape Analysis by Major End-Users

  • 7.3 North America RNAi for Therapeutic Landscape Analysis by Major Countries

    • 7.3.1 United States RNAi for Therapeutic Market Volume and Growth Rate

    • 7.3.2 Canada RNAi for Therapeutic Market Volume and Growth Rate

    • 7.3.3 Mexico RNAi for Therapeutic Market Volume and Growth Rate

8 Europe RNAi for Therapeutic Landscape Analysis

  • 8.1 Europe RNAi for Therapeutic Landscape Analysis by Major Types

  • 8.2 Europe RNAi for Therapeutic Landscape Analysis by Major End-Users

  • 8.3 Europe RNAi for Therapeutic Landscape Analysis by Major Countries

    • 8.3.1 Germany RNAi for Therapeutic Market Volume and Growth Rate

    • 8.3.2 UK RNAi for Therapeutic Market Volume and Growth Rate

    • 8.3.3 France RNAi for Therapeutic Market Volume and Growth Rate

    • 8.3.4 Italy RNAi for Therapeutic Market Volume and Growth Rate

    • 8.3.5 Nordic Countries RNAi for Therapeutic Market Volume and Growth Rate

    • 8.3.6 Spain RNAi for Therapeutic Market Volume and Growth Rate

    • 8.3.7 Belgium RNAi for Therapeutic Market Volume and Growth Rate

    • 8.3.8 Poland RNAi for Therapeutic Market Volume and Growth Rate

    • 8.3.9 Russia RNAi for Therapeutic Market Volume and Growth Rate

    • 8.3.10 Turkey RNAi for Therapeutic Market Volume and Growth Rate

9 Asia Pacific RNAi for Therapeutic Landscape Analysis

  • 9.1 Asia Pacific RNAi for Therapeutic Landscape Analysis by Major Types

  • 9.2 Asia Pacific RNAi for Therapeutic Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific RNAi for Therapeutic Landscape Analysis by Major Countries

    • 9.3.1 China RNAi for Therapeutic Market Volume and Growth Rate

    • 9.3.2 Japan RNAi for Therapeutic Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand RNAi for Therapeutic Market Volume and Growth Rate

    • 9.3.4 India RNAi for Therapeutic Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries RNAi for Therapeutic Market Volume and Growth Rate

    • 9.3.6 South Korea RNAi for Therapeutic Market Volume and Growth Rate

10 Latin America, Middle East & Africa RNAi for Therapeutic Landscape Analysis

  • 10.1 Latin America, Middle East & Africa RNAi for Therapeutic Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa RNAi for Therapeutic Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa RNAi for Therapeutic Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries RNAi for Therapeutic Market Volume and Growth Rate

    • 10.3.2 Brazil RNAi for Therapeutic Market Volume and Growth Rate

    • 10.3.3 Nigeria RNAi for Therapeutic Market Volume and Growth Rate

    • 10.3.4 South Africa RNAi for Therapeutic Market Volume and Growth Rate 

    • 10.3.5 Argentina RNAi for Therapeutic Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Alnylam Pharmaceuticals

    • 11.1.1 Alnylam Pharmaceuticals Company Profile and Development Status

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Ensysce Biosciences

    • 11.2.1 Ensysce Biosciences Company Profile and Development Status

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Silenseed

    • 11.3.1 Silenseed Company Profile and Development Status

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Roche Innovation Center Copenhagen (formerly Santaris Pharma)

    • 11.4.1 Roche Innovation Center Copenhagen (formerly Santaris Pharma) Company Profile and Development Status

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 RXi Pharmaceuticals

    • 11.5.1 RXi Pharmaceuticals Company Profile and Development Status

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Benitec Biopharma

    • 11.6.1 Benitec Biopharma Company Profile and Development Status

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Silence Therapeutics

    • 11.7.1 Silence Therapeutics Company Profile and Development Status

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Celsion Corporation

    • 11.8.1 Celsion Corporation Company Profile and Development Status

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 CombiMatrix

    • 11.9.1 CombiMatrix Company Profile and Development Status

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Biogazelle

    • 11.10.1 Biogazelle Company Profile and Development Status

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Sylentis

    • 11.11.1 Sylentis Company Profile and Development Status

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Bayer Heathcare

    • 11.12.1 Bayer Heathcare Company Profile and Development Status

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 Quark Pharmaceuticals

    • 11.13.1 Quark Pharmaceuticals Company Profile and Development Status

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Arrowhead Research

    • 11.14.1 Arrowhead Research Company Profile and Development Status

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 Calando Pharmaceuticals

    • 11.15.1 Calando Pharmaceuticals Company Profile and Development Status

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

  • 11.16 Celgene

    • 11.16.1 Celgene Company Profile and Development Status

    • 11.16.2 Market Performance

    • 11.16.3 Product and Service Introduction

  • 11.17 Astellas Pharma

    • 11.17.1 Astellas Pharma Company Profile and Development Status

    • 11.17.2 Market Performance

    • 11.17.3 Product and Service Introduction

  • 11.18 Tekmira Pharmaceuticals.

    • 11.18.1 Tekmira Pharmaceuticals. Company Profile and Development Status

    • 11.18.2 Market Performance

    • 11.18.3 Product and Service Introduction

  • 11.19 AstraZeneca

    • 11.19.1 AstraZeneca Company Profile and Development Status

    • 11.19.2 Market Performance

    • 11.19.3 Product and Service Introduction

  • 11.20 Ascletis Pharmaceuticals

    • 11.20.1 Ascletis Pharmaceuticals Company Profile and Development Status

    • 11.20.2 Market Performance

    • 11.20.3 Product and Service Introduction

  • 11.21 GeneCopoeia

    • 11.21.1 GeneCopoeia Company Profile and Development Status

    • 11.21.2 Market Performance

    • 11.21.3 Product and Service Introduction

  • 11.22 Gradalis Incorporated

    • 11.22.1 Gradalis Incorporated Company Profile and Development Status

    • 11.22.2 Market Performance

    • 11.22.3 Product and Service Introduction

  • 11.23 Creative Animodel

    • 11.23.1 Creative Animodel Company Profile and Development Status

    • 11.23.2 Market Performance

    • 11.23.3 Product and Service Introduction

  • 11.24 BioSpring

    • 11.24.1 BioSpring Company Profile and Development Status

    • 11.24.2 Market Performance

    • 11.24.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 102 Figures and 132 Tables)

  • Figure Product Picture

  • Figure Global RNAi for Therapeutic Market Size and Growth Rate of siRNA from 2014 to 2026

  • Figure Global RNAi for Therapeutic Market Size and Growth Rate of miRNA from 2014 to 2026

  • Figure Global RNAi for Therapeutic Market Size and Growth Rate of shRNA from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global RNAi for Therapeutic Market Size and Growth Rate of Cancer from 2014 to 2026

  • Figure Global RNAi for Therapeutic Market Size and Growth Rate of Cardiovascular from 2014 to 2026

  • Figure Global RNAi for Therapeutic Market Size and Growth Rate of HBV from 2014 to 2026

  • Figure Global RNAi for Therapeutic Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of RNAi for Therapeutic Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of RNAi for Therapeutic

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of RNAi for Therapeutic by Different Types from 2014 to 2026

  • Table Consumption Share of RNAi for Therapeutic by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of siRNA

  • Figure Market Size and Growth Rate of miRNA

  • Figure Market Size and Growth Rate of shRNA

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of RNAi for Therapeutic by Different End-Users from 2014 to 2026

  • Table Consumption Share of RNAi for Therapeutic by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Cancer

  • Figure Market Size and Growth Rate of Cardiovascular

  • Figure Market Size and Growth Rate of HBV

  • Figure Market Size and Growth Rate of Others

  • Table Global RNAi for Therapeutic Production by Major Regions

  • Table Global RNAi for Therapeutic Production Share by Major Regions

  • Figure Global RNAi for Therapeutic Production Share by Major Regions in 2014

  • Figure Global RNAi for Therapeutic Production Share by Major Regions in 2018

  • Figure Global RNAi for Therapeutic Production Share by Major Regions in 2026

  • Table Global RNAi for Therapeutic Consumption by Major Regions

  • Table Global RNAi for Therapeutic Consumption Share by Major Regions

  • Figure Global RNAi for Therapeutic Consumption Share by Major Regions in 2014

  • Figure Global RNAi for Therapeutic Consumption Share by Major Regions in 2018

  • Figure Global RNAi for Therapeutic Consumption Share by Major Regions in 2026

  • Table North America RNAi for Therapeutic Production, Import, Consumption and Export Analysis

  • Table Europe RNAi for Therapeutic Production, Import, Consumption and Export Analysis

  • Table Asia Pacific RNAi for Therapeutic Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa RNAi for Therapeutic Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in RNAi for Therapeutic market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in RNAi for Therapeutic market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in RNAi for Therapeutic market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in RNAi for Therapeutic market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America RNAi for Therapeutic Consumption by Types from 2014 to 2026

  • Table North America RNAi for Therapeutic Consumption Share by Types from 2014 to 2026

  • Figure North America RNAi for Therapeutic Consumption Share by Types in 2014

  • Figure North America RNAi for Therapeutic Consumption Share by Types in 2018

  • Figure North America RNAi for Therapeutic Consumption Share by Types in 2026

  • Table North America RNAi for Therapeutic Consumption by End-Users from 2014 to 2026

  • Table North America RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026

  • Figure North America RNAi for Therapeutic Consumption Share by End-Users in 2014

  • Figure North America RNAi for Therapeutic Consumption Share by End-Users in 2018

  • Figure North America RNAi for Therapeutic Consumption Share by End-Users in 2026

  • Table North America RNAi for Therapeutic Consumption by Major Countries from 2014 to 2026

  • Table North America RNAi for Therapeutic Consumption Share by Major Countries from 2014 to 2026

  • Figure North America RNAi for Therapeutic Consumption Share by Major Countries in 2014

  • Figure North America RNAi for Therapeutic Consumption Share by Major Countries in 2018

  • Figure North America RNAi for Therapeutic Consumption Share by Major Countries in 2026

  • Figure United States RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Table Europe RNAi for Therapeutic Consumption by Types from 2014 to 2026

  • Table Europe RNAi for Therapeutic Consumption Share by Types from 2014 to 2026

  • Figure Europe RNAi for Therapeutic Consumption Share by Types in 2014

  • Figure Europe RNAi for Therapeutic Consumption Share by Types in 2018

  • Figure Europe RNAi for Therapeutic Consumption Share by Types in 2026

  • Table Europe RNAi for Therapeutic Consumption by End-Users from 2014 to 2026

  • Table Europe RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026

  • Figure Europe RNAi for Therapeutic Consumption Share by End-Users in 2014

  • Figure Europe RNAi for Therapeutic Consumption Share by End-Users in 2018

  • Figure Europe RNAi for Therapeutic Consumption Share by End-Users in 2026

  • Table Europe RNAi for Therapeutic Consumption by Major Countries from 2014 to 2026

  • Table Europe RNAi for Therapeutic Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe RNAi for Therapeutic Consumption Share by Major Countries in 2014

  • Figure Europe RNAi for Therapeutic Consumption Share by Major Countries in 2018

  • Figure Europe RNAi for Therapeutic Consumption Share by Major Countries in 2026

  • Figure Germany RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure UK RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure France RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific RNAi for Therapeutic Consumption by Types from 2014 to 2026

  • Table Asia Pacific RNAi for Therapeutic Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific RNAi for Therapeutic Consumption Share by Types in 2014

  • Figure Asia Pacific RNAi for Therapeutic Consumption Share by Types in 2018

  • Figure Asia Pacific RNAi for Therapeutic Consumption Share by Types in 2026

  • Table Asia Pacific RNAi for Therapeutic Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific RNAi for Therapeutic Consumption Share by End-Users in 2014

  • Figure Asia Pacific RNAi for Therapeutic Consumption Share by End-Users in 2018

  • Figure Asia Pacific RNAi for Therapeutic Consumption Share by End-Users in 2026

  • Table Asia Pacific RNAi for Therapeutic Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific RNAi for Therapeutic Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific RNAi for Therapeutic Consumption Share by Major Countries in 2014

  • Figure Asia Pacific RNAi for Therapeutic Consumption Share by Major Countries in 2018

  • Figure Asia Pacific RNAi for Therapeutic Consumption Share by Major Countries in 2026

  • Figure China RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandRNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure India RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa RNAi for Therapeutic Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa RNAi for Therapeutic Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa RNAi for Therapeutic Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa RNAi for Therapeutic Consumption Share by Major Countries in 2026

  • Figure GCC Countries RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina RNAi for Therapeutic Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Alnylam Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals

  • Table Product and Service Introduction of Alnylam Pharmaceuticals

  • Table Company Profile and Development Status of Ensysce Biosciences

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ensysce Biosciences

  • Figure Sales and Growth Rate Analysis of Ensysce Biosciences

  • Figure Revenue and Market Share Analysis of Ensysce Biosciences

  • Table Product and Service Introduction of Ensysce Biosciences

  • Table Company Profile and Development Status of Silenseed

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silenseed

  • Figure Sales and Growth Rate Analysis of Silenseed

  • Figure Revenue and Market Share Analysis of Silenseed

  • Table Product and Service Introduction of Silenseed

  • Table Company Profile and Development Status of Roche Innovation Center Copenhagen (formerly Santaris Pharma)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Innovation Center Copenhagen (formerly Santaris Pharma)

  • Figure Sales and Growth Rate Analysis of Roche Innovation Center Copenhagen (formerly Santaris Pharma)

  • Figure Revenue and Market Share Analysis of Roche Innovation Center Copenhagen (formerly Santaris Pharma)

  • Table Product and Service Introduction of Roche Innovation Center Copenhagen (formerly Santaris Pharma)

  • Table Company Profile and Development Status of RXi Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of RXi Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of RXi Pharmaceuticals

  • Figure Revenue and Market Share Analysis of RXi Pharmaceuticals

  • Table Product and Service Introduction of RXi Pharmaceuticals

  • Table Company Profile and Development Status of Benitec Biopharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Benitec Biopharma

  • Figure Sales and Growth Rate Analysis of Benitec Biopharma

  • Figure Revenue and Market Share Analysis of Benitec Biopharma

  • Table Product and Service Introduction of Benitec Biopharma

  • Table Company Profile and Development Status of Silence Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silence Therapeutics

  • Figure Sales and Growth Rate Analysis of Silence Therapeutics

  • Figure Revenue and Market Share Analysis of Silence Therapeutics

  • Table Product and Service Introduction of Silence Therapeutics

  • Table Company Profile and Development Status of Celsion Corporation

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celsion Corporation

  • Figure Sales and Growth Rate Analysis of Celsion Corporation

  • Figure Revenue and Market Share Analysis of Celsion Corporation

  • Table Product and Service Introduction of Celsion Corporation

  • Table Company Profile and Development Status of CombiMatrix

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CombiMatrix

  • Figure Sales and Growth Rate Analysis of CombiMatrix

  • Figure Revenue and Market Share Analysis of CombiMatrix

  • Table Product and Service Introduction of CombiMatrix

  • Table Company Profile and Development Status of Biogazelle

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogazelle

  • Figure Sales and Growth Rate Analysis of Biogazelle

  • Figure Revenue and Market Share Analysis of Biogazelle

  • Table Product and Service Introduction of Biogazelle

  • Table Company Profile and Development Status of Sylentis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sylentis

  • Figure Sales and Growth Rate Analysis of Sylentis

  • Figure Revenue and Market Share Analysis of Sylentis

  • Table Product and Service Introduction of Sylentis

  • Table Company Profile and Development Status of Bayer Heathcare

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Heathcare

  • Figure Sales and Growth Rate Analysis of Bayer Heathcare

  • Figure Revenue and Market Share Analysis of Bayer Heathcare

  • Table Product and Service Introduction of Bayer Heathcare

  • Table Company Profile and Development Status of Quark Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quark Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Quark Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Quark Pharmaceuticals

  • Table Product and Service Introduction of Quark Pharmaceuticals

  • Table Company Profile and Development Status of Arrowhead Research

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrowhead Research

  • Figure Sales and Growth Rate Analysis of Arrowhead Research

  • Figure Revenue and Market Share Analysis of Arrowhead Research

  • Table Product and Service Introduction of Arrowhead Research

  • Table Company Profile and Development Status of Calando Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Calando Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Calando Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Calando Pharmaceuticals

  • Table Product and Service Introduction of Calando Pharmaceuticals

  • Table Company Profile and Development Status of Celgene

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene

  • Figure Sales and Growth Rate Analysis of Celgene

  • Figure Revenue and Market Share Analysis of Celgene

  • Table Product and Service Introduction of Celgene

  • Table Company Profile and Development Status of Astellas Pharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

  • Figure Sales and Growth Rate Analysis of Astellas Pharma

  • Figure Revenue and Market Share Analysis of Astellas Pharma

  • Table Product and Service Introduction of Astellas Pharma

  • Table Company Profile and Development Status of Tekmira Pharmaceuticals.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tekmira Pharmaceuticals.

  • Figure Sales and Growth Rate Analysis of Tekmira Pharmaceuticals.

  • Figure Revenue and Market Share Analysis of Tekmira Pharmaceuticals.

  • Table Product and Service Introduction of Tekmira Pharmaceuticals.

  • Table Company Profile and Development Status of AstraZeneca

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

  • Figure Sales and Growth Rate Analysis of AstraZeneca

  • Figure Revenue and Market Share Analysis of AstraZeneca

  • Table Product and Service Introduction of AstraZeneca

  • Table Company Profile and Development Status of Ascletis Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ascletis Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Ascletis Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Ascletis Pharmaceuticals

  • Table Product and Service Introduction of Ascletis Pharmaceuticals

  • Table Company Profile and Development Status of GeneCopoeia

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GeneCopoeia

  • Figure Sales and Growth Rate Analysis of GeneCopoeia

  • Figure Revenue and Market Share Analysis of GeneCopoeia

  • Table Product and Service Introduction of GeneCopoeia

  • Table Company Profile and Development Status of Gradalis Incorporated

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gradalis Incorporated

  • Figure Sales and Growth Rate Analysis of Gradalis Incorporated

  • Figure Revenue and Market Share Analysis of Gradalis Incorporated

  • Table Product and Service Introduction of Gradalis Incorporated

  • Table Company Profile and Development Status of Creative Animodel

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Creative Animodel

  • Figure Sales and Growth Rate Analysis of Creative Animodel

  • Figure Revenue and Market Share Analysis of Creative Animodel

  • Table Product and Service Introduction of Creative Animodel

  • Table Company Profile and Development Status of BioSpring

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioSpring

  • Figure Sales and Growth Rate Analysis of BioSpring

  • Figure Revenue and Market Share Analysis of BioSpring

  • Table Product and Service Introduction of BioSpring


Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top